Severe community-acquired pneumonia: Risk factors and follow-up epidemiology

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 923-929

  Ruiz, Mauricio ^a   Ewig, Santiago ^a,b   Torres, Antoni ^a,c   Arancibia, Francisco ^a   Marco, Francesc ^a   Mensa, Josep ^a   Sanchez, Miguel ^a   Martinez, Jose Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; IMIPENEM; LINEZOLID; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE UNIT; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; MICROORGANISM; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STREPTOCOCCUS PNEUMONIA;

EID: 0032860830     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9901107     Document Type: Article

References (24)

1. Woodhead, M. A., J. T. McFarlanc, F.G. Rodgers, A. Laverick, R. Pilkington, and A. D. Macrae. 1985. Aetiology and outcome of severe community-acquired pneumonia. J. Infect. 10:204-210.
2. Pachon, J., M. D. Prado, F. Capote, J. A. Cuello, J. Garnacho, and A. Verano. 1990. Severe community acquired pneumonia. Am. Rev. Respir. Dis. 142:369-373.
3. Torres, A., J. Serra-Batlles, A. Ferrer, P. Jimenez, R. Celis, E. Cobo, and R. Rodriguez-Roisin. 1991. Severe community acquired pneumonia: epidemiology and prognosis factors. Am. Rev. Respir. Dis. 114:312-318.
4. British Thoracic Society Research Committee and The Public Health Laboratory Service. 1992. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. Respir. Med. 86:7-13.
5. Rello, J., E. Quintana, V. Ausina, A. Net, and G. Prats. 1993. A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 103:232-235.
6. Moine, P., J. B. Vercken, S. Chevret, C. Castang, P. Gajdos, and the French Study Group for Community-acquired Pneumonia in the Intensive Care Unit. 1994, Severe community-acquired pneumonia: etiology, epidemiology, and prognosis factors. Chest 105:1487-1495.
7. Leroy, O., C. Santre, C. Beuscart, H. Georges, B. Guery, J. M. Jacquier, and G. Beaucaire. 1995. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med. 21:24-31.
8. Feldman, C., S. Ross, A. G. Mahomed, J. Omar, and C. Smith. 1995. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir. Med, 89:187-192.
9. Rello, J., R. Rodriguez, P. Jubert, B. Alvarez, and the Study Group for Severe Community-acquired Pneumonia. 1996. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clin. Infect. Dis. 23:723-728.
10. Hirani, N. A., and J. T. Macfarlane. 1997. Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax 52:17-21.
11. Balows, A., and W. J. Harsier, Jr. 1991. Manual of Clinical Microbiology, 5th ed. American Society of Microbiology, Washington, DC. 209-553.
12. American Thoracic Society. 1993. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis. 148:1418-1426.
13. Ewig, S., M. Ruiz, J. Mensa, M. A. Marcos, J. A. Martinez, M. S. Niederman, and A. Torres. 1998. Severe community-acquired pneumonia -assessment of severity criteria. Am. J. Respir. Crit. Care Med. 158:1102-1108.
14. Almirall, J., E. Mesalles, J. Klamburg, O. Parra, and A. Agudo. 1995. Prognostic Factors of pneumonia requiring admission to the intensive care unit. Chest 107:511-516.
15. Koivula, I., M. Sten, and P. H. Makela. 1994. Risk factors for pneumonia in the elderly. Am. J. Med. 96:313-320.
16. Fernandez-Sola, J., A. Junque, R. Estruch, R. Monforte, A. Torres, and A. Urbano-Marquez. 1995. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch. Intern. Med. 155: 1649-1654.
17. Krumpe, P. E., J. M. Cummiskey, and G. A. Lillington. 1984. Alcohol and the respiratory tract. Med. Clin. North Am. 68:201-209.
18. Nair, M. P., Z. A. Kronfol, and S. A. Swartz. 1990. Effects of alcohol and nicotine on cytoloxie functions of human lymphocytes. Clin. Immunol. Immunopathol. 54:395-409.
19. Ruiz, M., S. Ewig, M. A. Marcos, J. A. Martinez, F. Arancibia, J. Mensa, and A. Torres. 1999. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am. J. Respir. Crit. Care Med. (In press)
20. Nelson, S., C. M. Manson, J. Kolls, and W. R. Summer, 1995. Pathophysiology of pneumonia. Clin. Chest Med. 16:1-12
21. Torres, A., M. El-Ebiary, and C. Monton. 1996. The inflammatory response in pneumonia. In J.-L. Vincent, editor. Yearbook of Intensive Care Medicine. Springer Verlag, New York. 595-606.
22. Cosentini R, F. Blasi, R. Raccanelli, S. Rossi, C. Arosio, P. Tarsia, A. Randazzo, and L. Allegra. 1996. Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. Respiration 63:61-65.
23. Oleachea, P. M., J. M. Quintana, M. S. Gallardo, J. Insausti, E. Maravi, and B. Alvarez, 1996. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Intersive Care Med. 22:1294-1300.
24. Ewig, S., M. Ruiz, A. Torres, F. Marco, J. A. Martinez, M. Sanchez, and J. Mensa. 1999. Pneumonia acquired in the community due to drug resistant Streptococcus pneumoniae. Am. J. Respir. Crit. Care Med. (In press)